The condition of the New Jersey man who was admitted to the hospital with COVID-19, about a month after he received the Johnson & Johnson vaccine, worsened, his daughter told the New York Post.
Francisco Cosme, 52, of Edison is now in a ventilator, his daughter Michelle Torres said.
“He’s not aware, we’re just looking at him,” Torres told the Post.
New Jersey health commissioner Judy Persichilli said earlier that catching the virus after being vaccinated is rare, but could still happen. The U.S. Centers for Disease Control and Prevention said the J&J vaccine was 66.3% effective in clinical trials to prevent disease and that it is highly effective in preventing hospitalization and death in those who become ill. .
“It will happen,” Persichilli said recently at a COVID-19 briefing. “The efficacy can be almost 100%, but there are also a percentage of cases that COVID-19 contracted before being vaccinated, or then exposed and will become ill.”
Attempts to reach Cosme’s family by telephone were unsuccessful on Saturday morning.
The CDC said there were reports this week of 5,800 breakthrough infections among the nearly 77 million people in the United States who had been fully vaccinated. These breakthrough infections would represent 0.007% of those vaccinated. Seventy-four people died after receiving the vaccination, the CDC said.
Government Phil Murphy said earlier this week there is no data to confirm that cases like Cosme are the norm.
“There are so few cases in Jersey, in the country, in the world where someone is infected after the vaccination,” he said. ‘I just do not want anyone out there to assume that this is the norm, because it is not so. There is no data to suggest this at all. ”
Cosme, who is believed to be diabetic, received the Johnson & Johnson vaccine on March 6 and was rushed to the John F. Kennedy Medical Center, his family told the Post. He started getting symptoms on April 1st.
According to the CDC, no one who received COVID-19 needs to be hospitalized in clinical trials at least four weeks after receiving the J&J vaccine. People had the most protection two weeks after being vaccinated.
New Jersey halted the administration of the J&J vaccine on Tuesday after federal health officials recommended it. The decision came after six women had blood clots six to 13 days after receiving the J&J vaccine.
The governor said about 235,000 doses of the J&J vaccine had been administered in New Jersey and that there were reportedly no similar adverse effects. Medical experts believe that although the cases need to be investigated, the risks are still low.
Local journalism needs your support. Sign in to nj.com/supporter.
Rebecca Panico can be reached at [email protected].
Read more